- Home
- RNAZ vs JXG Comparison
RNAZ vs JXG Comparison
Compare RNAZ & JXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAZ
- JXG
- Stock Information
- Founded
- RNAZ 2016
- JXG N/A
- Country
- RNAZ United States
- JXG China
- Employees
- RNAZ N/A
- JXG N/A
- Industry
- RNAZ Biotechnology: Pharmaceutical Preparations
- JXG
- Sector
- RNAZ Health Care
- JXG
- Exchange
- RNAZ Nasdaq
- JXG Nasdaq
- Market Cap
- RNAZ 8.7M
- JXG 10.4M
- IPO Year
- RNAZ 2021
- JXG N/A
- Fundamental
- Price
- RNAZ $15.00
- JXG $0.88
- Analyst Decision
- RNAZ Strong Buy
- JXG
- Analyst Count
- RNAZ 1
- JXG 0
- Target Price
- RNAZ $280.00
- JXG N/A
- AVG Volume (30 Days)
- RNAZ 13.8K
- JXG 1.8M
- Earning Date
- RNAZ 11-13-2025
- JXG 05-15-2025
- Dividend Yield
- RNAZ N/A
- JXG N/A
- EPS Growth
- RNAZ N/A
- JXG N/A
- EPS
- RNAZ N/A
- JXG 0.86
- Revenue
- RNAZ N/A
- JXG $49,840,288.00
- Revenue This Year
- RNAZ N/A
- JXG N/A
- Revenue Next Year
- RNAZ N/A
- JXG N/A
- P/E Ratio
- RNAZ N/A
- JXG $0.99
- Revenue Growth
- RNAZ N/A
- JXG 56.53
- 52 Week Low
- RNAZ $6.15
- JXG $0.55
- 52 Week High
- RNAZ $739.20
- JXG $7.72
- Technical
- Relative Strength Index (RSI)
- RNAZ 84.37
- JXG 48.11
- Support Level
- RNAZ $10.32
- JXG $0.83
- Resistance Level
- RNAZ $12.28
- JXG $0.90
- Average True Range (ATR)
- RNAZ 0.87
- JXG 0.09
- MACD
- RNAZ 0.57
- JXG 0.01
- Stochastic Oscillator
- RNAZ 91.34
- JXG 48.63
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.
About JXG JX Luxventure Limited Common Stock
JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products.